Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Quest Diagnostics Inc (DGX) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 12,910,160
  • Shares Outstanding, K 138,640
  • Annual Sales, $ 7,493 M
  • Annual Income, $ 709 M
  • 36-Month Beta 0.66
  • Price/Sales 1.72
  • Price/Book 2.75

Price Performance

See More
Period Period Low Period High Performance
1-Month
91.25 +1.11%
on 12/22/16
93.84 -1.68%
on 01/11/17
-0.05 (-0.05%)
since 12/16/16
3-Month
79.12 +16.61%
on 10/28/16
93.84 -1.68%
on 01/11/17
+9.22 (+11.10%)
since 10/17/16
52-Week
59.66 +54.64%
on 02/09/16
93.84 -1.68%
on 01/11/17
+26.49 (+40.28%)
since 01/15/16

Most Recent Stories

More News
Quest Diagnostics (DGX) Q4 Earnings: What Lies in Store?

Quest Diagnostics Inc. (DGX) is scheduled to report fourth-quarter and full-year 2016 earnings results before the opening bell on Jan 26, 2017.

Quest Diagnostics To Release Fourth Quarter And Full Year 2016 Financial Results On January 26

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2016 results on Thursday, January...

Anthem Extends Alliance with Inovalon, Boosts Customer Value

Leading U.S.-based Health Maintenance Organization (HMO), Anthem Inc. (ANTM), recently declared a multi-year extension of its partnership with Inovalon Holdings, Inc. (INOV).

Inovalon Extends Partnership With Anthem

Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the healthcare ecosystem,...

Quest Diagnostics To Speak At The 35th Annual J.P. Morgan Healthcare Conference

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 35th Annual J.P. Morgan Healthcare Conference...

Quest Diagnostics: Strong Q3, Strategic Initiatives Add Value

On Dec 27, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).

Research and Markets - Non-Invasive Prenatal Testing Market to Reach $5.5 Billion by 2025 with Natera, Illumina & Quest Diagnostics Dominating

DUBLIN, Dec 20, 2016 /PRNewswire/ --

Clinical Genomics Announces the Launch of Colvera(TM) for Colorectal Cancer Recurrence Monitoring

Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the launch of Colvera, a blood-based test for colorectal cancer (CRC) recurrence monitoring....

Griffin-American Healthcare REIT IV Acquires Evendale Medical Office Building Near Cincinnati

American Healthcare Investors and Griffin Capital Corporation, the co-sponsors of Griffin-American Healthcare REIT IV, Inc., announced today that the REIT has acquired Evendale Medical Office Building,...

Quest Diagnostics Board of Directors Elects Stephen H. Rusckowski Chairman of the Board

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostics information services, today announced that its Board of Directors elected Stephen H. Rusckowski, the company's President and Chief...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers,...

See More

Support & Resistance

2nd Resistance Point 93.17
1st Resistance Point 92.72
Last Price 92.26
1st Support Level 91.75
2nd Support Level 91.23

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.